10x Genomics(GB:0A88)
$59.40-4.97 (-7.72%)
GB:0A88
10x Genomics ownership
$59.40
At close:-4.97 (-7.72%)
10x Genomics (0A88) Ownership - Who Owns 10x Genomics?
6 Followers
10x Genomics (0A88) Ownership Overview
- 2.26% Insiders
- 29.54% Mutual Funds
- 4.71% Other Institutional Investors
- 23.83% ETFs
- 39.67% Public Companies and Individual Investors
The ownership structure of 10x Genomics (GB:0A88) stock is a mix of institutional, retail, and individual investors. Approximately 58.08% of the company’s stock is owned by Institutional Investors, 2.26% is owned by Insiders, and 39.67% is owned by Public Companies and Individual Investors.
The ownership structure of 10x Genomics (GB:0A88) stock is a mix of institutional, retail, and individual investors. Approximately 58.08% of the company’s stock is owned by Institutional Investors, 2.26% is owned by Insiders, and 39.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 12, 2026 | Serge Saxonov | $1,949,900 | |
| Sep 07, 2026 | John Stuelpnagel | $1,234,920 | |
| Aug 25, 2026 | Serge Saxonov | $1,168,706 | |
| Aug 25, 2026 | Adam Taich | $1,081,801 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Deerfield Management Company, Lp | $2,064,421 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | $2,898,841 | |
| Dec 31, 2025 | Clough Capital Partners L P | $9,955,199 | |
| Dec 31, 2025 | Ark Investment Management Llc | $206,604,788 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 10,804,070 | Institution | 8.99% | 641,761,758 |
| Vanguard | 10,746,073 | Institution | 8.94% | 638,316,736 |
| Cathie Wood | 10,003,057 | Institution | 8.32% | 594,181,586 |
| Vanguard Index Funds | 8,885,471 | Institution | 7.39% | 527,796,977 |
| Ishares | 5,952,961 | Institution | 4.95% | 353,605,883 |
| Ark | 5,221,042 | Institution | 4.34% | 310,129,895 |
| Fidelity Select Portfolios | 3,632,090 | Institution | 3.02% | 215,746,146 |
| Fidelity Rutland Square Trust Ii | 1,809,260 | Institution | 1.51% | 107,470,044 |
| T. Rowe Price New Horizons Fund, Inc. | 1,458,300 | Institution | 1.21% | 86,623,020 |
| Smallcap World Fund Inc | 1,452,300 | Institution | 1.21% | 86,266,620 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 8,885,471 | Institution | 7.39% | 527,796,977 |
| Fidelity Select Portfolios | 3,632,090 | Institution | 3.02% | 215,746,146 |
| Fidelity Rutland Square Trust Ii | 1,809,260 | Institution | 1.51% | 107,470,044 |
| T. Rowe Price New Horizons Fund, Inc. | 1,458,300 | Institution | 1.21% | 86,623,020 |
| Smallcap World Fund Inc | 1,452,300 | Institution | 1.21% | 86,266,620 |
| Fidelity Salem Street Trust | 1,433,087 | Institution | 1.19% | 85,125,368 |
| T. Rowe Price Integrated Equity Funds, Inc. | 1,376,433 | Institution | 1.15% | 81,760,120 |
| Fidelity Securities Fund | 1,312,213 | Institution | 1.09% | 77,945,452 |
| Fidelity Concord Street Trust | 1,241,975 | Institution | 1.03% | 73,773,315 |
| Vanguard Horizon Funds | 1,156,392 | Institution | 0.96% | 68,689,685 |
FAQ
Who Owns 10x Genomics (GB:0A88)?
According to the latest TipRanks data, approximately 58.08% of the company's stock is held by institutional investors, 2.26% is held by insiders, and 39.67% is held by public companies and individual investors.
What percentage of 10x Genomics (GB:0A88) stock is held by institutional investors?
According to the latest TipRanks data, approximately 58.08% of 10x Genomics (GB:0A88) stock is held by institutional investors: 29.54% by mutual funds, 23.83% by ETFs and 4.71% by other institutional investors.
What percentage of 10x Genomics (GB:0A88) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.67% of 10x Genomics (GB:0A88) stock is held by public companies and individual investors.
Who owns the most shares of 10x Genomics (GB:0A88)?
BlackRock, Inc. owns the most shares of 10x Genomics (GB:0A88).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
